Unlock instant, AI-driven research and patent intelligence for your innovation.

Polypeptide organic compound and use thereof in hetero transplantation

An organic compound and xenotransplantation technology, applied in the field of organic compounds and polypeptide organic compounds, can solve the problems of hair loss, ineffective hyperacute rejection of xenotransplantation, upper gastrointestinal bleeding, etc., and achieve the effect of avoiding side effects

Inactive Publication Date: 2008-07-30
ZHEJIANG UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, the commonly used immunosuppressants include cyclosporine A, glucocorticoids, azathioprine, cyclophosphamide, etc., which can reduce the overall immune response, but are ineffective against hyperacute rejection of xenotransplantation and have various side effects. Such as common bone marrow suppression, liver and kidney toxicity, upper gastrointestinal bleeding, hair loss, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polypeptide organic compound and use thereof in hetero transplantation
  • Polypeptide organic compound and use thereof in hetero transplantation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Example 1: Using anti-B blood monoclonal antibody as the target protein, phage display technology was used to screen to obtain positive phage clones.

[0019] Phage display technology uses molecular biology technology to clone a set of synthetic oligonucleotide fragments with a certain length of random sequence into a specific expression vector, so that the expression product is displayed on the surface of the phage in the form of a fusion protein. Since the peptide library contains all possible amino acid sequences of the small peptides of this length, each phage surface protein presents one of the peptides, which is convenient for screening; the screened phage can be amplified by bacteria. The phage peptide library is used to infect E. coli, and the random oligonucleotide fragments recombined into the phage are replicated in E. coli and expressed in the coat protein of the phage. Then, the target protein is coated on the ELISA plate. After mixing this phage peptide librar...

Embodiment 2

[0022] Example 2: Stachyose competitive ELISA experiment

[0023] Test method: Coat 100μl of anti-B blood monoclonal antibody in a 96-well ELISA plate at 4°C overnight, block with 5% BSA at 37°C for 2 hours, then wash the plate 3 times with TBS, add 100μl of positive phage and the final concentration respectively The mixture of 100, 20, 4, 0.8, 0.16, 0.032 mM stachyose was reacted for 1 hour, and a positive phage solution without stachyose was set as a blank control. Wash the plate 6 times with TBS containing 0.1% Tween 20, add 100 μl horseradish peroxidase labeled anti-M13 antibody, bind for 1 hour, wash the plate 6 times with TBS containing 0.1% Tween 20, develop color with TMB, and use enzyme The standard instrument measures the absorbance. Calculate the inhibition rate according to the formula: [A 450 (-s)-A 450 (+s)] / A 450 (-s)×100%, A 450 (-s) is the absorbance without stachyose, A 450 (+s) is the absorbance of adding stachyose.

[0024] Test results: Stachyose can effective...

Embodiment 3

[0026] Example 3: Polypeptides inhibit the agglutination reaction between human serum and porcine red blood cells

[0027]Test method: The prepared fresh 1% porcine red blood cells were suspended in phosphate buffer at pH 7.4 for later use. In the wells of the U-type hemagglutination plate, 40μl of peptides were diluted with phosphate buffer sequentially, and then 40μl of appropriately diluted type A human serum and 40μl of 1% porcine red blood cells were added to each well. Then, the mixed solution was shaken with a shaker for 1 minute at room temperature, and then allowed to stand for 1 hour before observing the result of agglutination. If the red blood cells settle to the bottom of the hole as a round dot with a smooth edge, then this is no agglutination. If the red blood cells form a network and do not sink to the bottom of the hole to form a round dot with a smooth edge, this is agglomeration. The test has blank, positive and negative controls.

[0028] Test result: This pept...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a polypeptide organic compound. The polypeptide organic compound is chosen from a polypeptide organic compound g which has amino acid sequence of Cys-His-Gln-Thr-Pro-Leu-Ser-Thr-Cys, wherein, a disulfide bond is formed between Cys at first place and Cys at ninth place, and the polypeptide organic compound g has molecular weight of 987.13, can be combined with the specificity of an anti-B type blood monoclonal antibody and dissolved in water, and amino acids are connected through a peptide bond. The polypeptide organic compound of the invention can be combined with the anti-pig and antigen antibody specificity pre-stored in the human body, thereby blocking the function of the specificity; the polypeptide organic compound can characteristically block the hyperacute rejection reaction in Xenotransplantation, and the binding site of the polypeptide organic compound with the natural anti-alpha-Gal antibody pre-stored in the human body is idiosyncratic, which timely plays function of blocking the antibody, but does not influence the whole immune response of the human body, and can avoid the side effect caused by the common immune inhibitor.

Description

[0001] (This case is a divisional application with application number 2006100501640) Technical field [0002] The present invention belongs to organic compounds, and mainly relates to polypeptide organic compounds, in particular to artificially synthesized polypeptide organic compounds and their application in xenotransplantation. technical background [0003] Advances in medical technology have made it possible to transplant human organs. Due to insufficient sources of human organs, a large number of patients cannot obtain urgently needed organs. The use of pig organs to replace human organs is a hot research topic. However, due to the presence of heterologous epitope Gal-α-1,3-Gal on the cell surface of pigs, it can combine with the natural antibodies pre-existing in the human body to produce hyperacute rejection, resulting in the failure of xenotransplantation. People are struggling to find a way to block or eliminate human natural anti-α-Gal antibodies and open up a way for xe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K7/06A61K38/08A61P37/06
Inventor 詹金彪郎建社许林海严志焜
Owner ZHEJIANG UNIV